Inhibiting protein function selectively is a major goal of modern drug discovery. Here, we report a previously understudied benefit of small molecule proteolysis-targeting chimeras (PROTACs) that recruit E3 ubiquitin ligases to target proteins for their ubiquitination and subsequent proteasome-mediated degradation. Using promiscuous CRBN- and VHL-recruiting PROTACs that bind >50 kinases, we show that only a subset of bound targets is degraded. The basis of this selectivity relies on protein-protein interactions between the E3 ubiquitin ligase and the target protein, as illustrated by engaged proteins that are not degraded as a result of unstable ternary complexes with PROTAC-recruited E3 ligases. In contrast, weak PROTAC:target protein affinity can be stabilized by high-affinity target:PROTAC:ligase trimer interactions, leading to efficient degradation. This study highlights design guidelines for generating potent PROTACs as well as possibilities for degrading undruggable proteins immune to traditional small-molecule inhibitors.
Pubmed ID: 29129718 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.
View all literature mentionsThis monoclonal targets Axl (C2B12) Rabbit mAb
View all literature mentionsThis recombinant monoclonal targets Cullin 2
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis monoclonal targets Human ABL2
View all literature mentionsThis unknown targets IgG
View all literature mentionsThis monoclonal secondary targets IgG
View all literature mentionsThis monoclonal targets α-Tubulin
View all literature mentionsThis monoclonal targets Src
View all literature mentionsThis monoclonal targets Met
View all literature mentionsThis monoclonal targets p38-delta MAP Kinase
View all literature mentionsThis polyclonal targets p38 MAPK
View all literature mentionsThis monoclonal targets Mer
View all literature mentionsThis recombinant monoclonal targets GAPDH
View all literature mentionsThis monoclonal targets CDK4
View all literature mentionsThis monoclonal targets Phospho-Akt (Ser473)
View all literature mentionsThis monoclonal targets ABL1, BCR
View all literature mentionsThis monoclonal targets Axl (C2B12) Rabbit mAb
View all literature mentionsThis monoclonal targets Axl (C2B12) Rabbit mAb
View all literature mentions